NORD and 17 patient advocacy organizations submit comments to CMS on Oregon’s proposed Section 1115 waiver
Published: Apr 13, 2022
Tagged in: Access to Affordable, Adequate Coverage, Medicaid Section 1115 Waivers
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD and 17 patient advocacy organizations submit comments to CMS on Oregon’s proposed Section 1115 waiver
Published: Apr 13, 2022
Tagged in: Access to Affordable, Adequate Coverage, Medicaid Section 1115 Waivers
NORD comments to HHS regarding Oregon’s proposed Medicaid 1115 waiver renewal and the importance of accelerated approval treatments
Published: Apr 13, 2022
Tagged in: FDA’s Accelerated Approval Pathway, Access to Affordable, Adequate Coverage, Medicaid Section 1115 Waivers
NORD submits comments to the state of Oregon on the rare disease impact of proposals included in the draft 1115 Demonstration Waiver for the Oregon Health Plan.
Published: Jan 6, 2022
Tagged in: Access to Affordable, Adequate Coverage, Medicaid Section 1115 Waivers
NORD letter to the Oregon Senate Committee on Health Care regarding utilization management
Published: Apr 30, 2021
Tagged in: Access to Affordable, Adequate Coverage, Utilization Management
NORD letter to the Oregon Senate Committee on Health Care in support of HB2508, a bill to improve telehealth access
Published: Apr 28, 2021
Tagged in: Telehealth
